Association between Prolonged Early Antibiotics and Outcomes in Extremely Preterm Infants

Sunday, April 24, 2022

10:00 AM – 10:15 AM US MT

Location: Convention Center: Mile High Ballroom 1 CD

CE: Enduring CME: 0.25

Publication Number: 2320.1

Amanda J. Zayek, Duke University Hospital, Durham, NC, United States; Michael Cotten, Duke University School of Medicine, Durham, NC, United States; Brian Smith, Duke University School of Medicine, Durham, NC, United States; Karen M. Puopolo, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Sagori Mukhopadhyay, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Reese H. Clark, MEDNAX, Myrtle Beach, SC, United States; Rachel G. Greenberg, Duke Clinical Research Institute, Durham, NC, United States

Presenting Author(s)

Amanda J. Zayek, MD
Resident
Duke University Hospital
Durham, North Carolina, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Amanda J. Zayek, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Michael Cotten, MD MHS: ● Cryo Cell International (Currently Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties).
● Origin Biosciences (Currently Ongoing) (Products/Services: Consultant).
● ReAlta Life Sciences (Currently Ongoing) (Products/Services: Consultant).

Brian Smith, MD MPH MHS: ● Nestle (Ended In the Past 24 Months) (Products/Services: Consultant).
● SPARC Pharma (Ended In the Past 24 Months) (Products/Services: Consultant).
● Tellus (Currently Ongoing) (Products/Services: Consultant).
● UCB (Currently Ongoing) (Products/Services: Consultant).

Karen M. Puopolo, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Sagori Mukhopadhyay, MD, MMSc: ● Roche Diagnostics (Ended In the Past 24 Months) (Products/Services: Contractor including contracted research).

Reese H. Clark, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Rachel G. Greenberg, MD, MB, MHS: ● Tellus Therapeutics (Currently Ongoing) (Products/Services: Consultant).